Search

Search Results

• 

  Bevacizumab and etoposide combination chemotherapy in patients with recurrent malignant gliomas who failed bevacizumab

  Beverly D. Fu, Mark E. Linskey, Daniela Annenelie Bota

  e6

  24-02-2012

  https://doi.org/10.4081/dts.2012.e6

  1508

  PDF: 728
• 

  Pre-clinical anticancer drugs screening: perspectives from emerging models of glioma biology

  Juan Sebastian Yakisich

  e1

  28-12-2010

  https://doi.org/10.4081/dts.2011.e1

  895

  PDF: 584

  HTML: 324
• 

  Depletion of drug-surviving glioma cells by a second phase treatment with low concentration of salinomycin

  Zahid M. Delwar, Dimitrios Avramidis, Åke Siden, Mabel Cruz, Juan Sebastian Yakisich

  e7

  15-06-2011

  https://doi.org/10.4081/dts.2011.e7

  1818

  PDF: 751

  Supplementary Table 1: 144
• 

  Antimetastatic therapy targeting aberrant sialylation profiles in cancer cells

  Da Yong Lu, Ting Ren Lu, Hong-Ying Wu

  e12

  08-09-2011

  https://doi.org/10.4081/dts.2011.e12

  1480

  PDF: 703
• 

  Intracellular delivery of NF-κB small interfering RNA for modulating therapeutic activities of classical anti-cancer drugs in human cervical cancer cells

  Anthony Stanislaus, Anil Philip Kunnath, Snigdha Tiash, Tahereh Fatemian, Nur Izyani Kamaruzman, Athirah Bakhtiar, Sayyad Mustak, Sharif Hossain, Toshihiro Akaike, Ezharul Hoque Chowdhury

  e7

  10-12-2013

  https://doi.org/10.4081/dts.2013.e7

  3717

  PDF: 793
• 

  Effective re-induction therapy with dasatinib and clofarabine in relapsed Philadelphia chromosome positive acute lymphoblastic leukemia

  Anne Loes van den Boom, H. Berna Beverloo, Vincent H.J. van der Velden, Arjan Lankester, Rob Pieters, C. Michel Zwaan

  e13

  21-12-2012

  https://doi.org/10.4081/dts.2012.e13

  3089

  PDF: 681
• 

  Challenges and limitations of targeting cancer stem cells and/or the tumour microenvironment

  Juan Sebastian Yakisich

  e10

  10-05-2012

  https://doi.org/10.4081/dts.2012.e10

  4892

  PDF: 1270